Sulforaphane for the chemoprevention of bladder cancer: molecular mechanism targeted approach

The clinical course for both early and late stage Bladder Cancer (BC) continues to be characterized by significant patient burden due to numerous occurrences and recurrences requiring frequent surveillance strategies, intravesical drug therapies, and even more aggressive treatments in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Leone, Andrew, Diorio, Gregory, Sexton, Wade, Schell, Michael, Alexandrow, Mark, Fahey, Jed W., Kumar, Nagi B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471065/
https://www.ncbi.nlm.nih.gov/pubmed/28423681
http://dx.doi.org/10.18632/oncotarget.16015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471065/
https://www.ncbi.nlm.nih.gov/pubmed/28423681
http://dx.doi.org/10.18632/oncotarget.16015

Ejemplares similares